Minor salivary gland carcino sarcoma is a rare malignancy with an ominous prognosis. This report recounts a single case ofsupraglottic minor salivary gland carcinosarcoma that was treated aggressively. We discuss the peculiarities ofthe histology, with special mention ofthe distinction that must be made between mucosal-origin and salivary-gland-origin carcinosarcoma. Carcinosarcomas are aggressive regardless of their origin, but differentiating their origin is important because the prognosis is worsefor those that arise in salivary glands than for those that originate in the surface epithelium. This report adds to the literature a new case ofminor salivarygland-origin carcinosarcoma involving the upper airway. It is the first case we could identify in which the supraglottis was involved.
epiglottis and extended along the left aryepiglottic fold . No lymphadenopathy was present.
The patient was taken to the operating room for biopsy and airway management. We observed a 3 x 3 x 4-cm supraglottic mass, with no involvement of the false vocal folds and no pre-epiglottic space extension. For safe airway management, a tracheostomy was performed. Biopsy revealed a poorly differentiated malignancy that was most consistent with a high-grade mucoepidermoid carcinoma. The patient balked at further management, and as a result, treatment was delayed for 3 weeks. During this delay , a 2 x 2-cm node became palpable in the left midjugular chain. The patient returned for treatment and underwent a supraglottic laryngectomy with negative surgical margins and a left modified neck dissection. Seven of 15 nodes in the left side of the neck had been invaded by metastatic tumor. Postoperative radiation therapy was delivered to the primary site and to both sides of the neck.
A percutaneous esophagogastrostomy tube was placed at the time of the laryngectomy, and the patient was decannulated 12 weeks after surgery . Initially her weight began to increase, but a progressive deterioration ensued within 6 months, and radiography detected mediastinal and pulmonary metastases. Palliative radiation therapy was delivered to the chest. The woman died 10 months after her initial diagnosis and 22 months after she had first noticed her symptoms.
Radiologic findings. Magnetic resonance imaging (MRI) performed at the initial presentation revealed the presence of an irregular, sharply defined, supraglottic, oval-shaped mass that measured 2.9 em in its maximum dimension (figure I) . Compared with muscle, the mass was isointense on spin-echo T'l-weighted (TR 800/TE 22) MRI and hyperintense on spin-echo T2-weighted (TR 2700/TE 90) MRI. Moderate diffuse enhancement was seen on gadodiamide-enhanced images .
Unenhanced computed tomography (CT) showed that the mass was slightly hypodense compared with muscle. The mass was centered in the supraglottis, and it involved the entire suprahyoid epiglottis, with pre-epiglottic space extension. The mass obscured the vallecula. Pathologic findings. The laryngectomy specimen contained a highly variega ted, poorly different iated malignancy that was centered in the subepithelial tissue . Much of the tumor was carcin omatous and made up of nests of basaloid cells that had small, densely hyperchromatic nuclei and scant amounts of cytoplasm. Other areas featured trabecular and cribriform pattern s with a distinct gland formation (figure 2). Mucin stai ns were foca lly positive. Although initi al sections did not show a sarcomatous co mpo ne nt, additional sec tions did reveal chondrosar comatous foc i that were characterized by a chondroid matrix surro unding numero us atypical nuclei (figure 3). These hypercellular chondro id areas were distinct from trapped remnants of norm al cartilage. Fascicles of undiffe rent iated malignant spindle cells were also identified.
The combination of carcinomatous and sarcomatous elements was diagnostic of carc inosarcoma. We concluded that this tumor most likely originated in the minor salivary gland based on its morphologic resemblance to 386 carcinosarco mas of major salivary glands, the lack of a distin ct in situ compon ent in the surface epithelium, and the fact that the tumor' s epicenter was in the submucosal tissue.
Discussion
Cont roversy has been a hallmark of our understanding of carcinosarcoma for nearly a centur y. The debat e stems from our uncert ainty over the pathogenesis of these rare malignant tumors." There are four propo sed etiologic factors: (1) a carcinoma (usually squamous) with a reactive mesenchymal proliferation (pseudosarcoma), (2) a so-called collision tumor, in which carcinoma and sarcoma arise simultaneously in a specific anatomic site, (3) a malign ancy arising in an embryonic rest of epithelial and mesench ymal tissues, and (4) a divergent differentiation of a carcin oma into sarcomatous components, or sarcomatoid carcinoma.
Each of the first three theories has a significant weakness. In fact, the first theory is no longer in favor becau se the spindle cell comp onent can metastasize indep endentl y of the carcinoma. For the collision tumor theor y to hold would require an unlikely occurrence-namely, that multipl e, sequential carcin ogenic events in two or more independent cell types would result in a malignant transform ation of each. The third theory, that malignancy arises in an embryonic rest ofepithelial and mesench ymal tissues, is simply a variation of the collision tumor hypothesis and has the same shortcomings.
Th e fourth theor y, that there is a divergent differenti ation of a carcinoma into sarcomatous components, appears to be the most likely explanation. Thi s model requires the malignant tran sformati on of only a single cell line, which can then under go clon al evolution and differenti ation into a variety of carcinomatou s and sarcomatous components. These tumors can originate in stem (totipotent ial) cells in a manner somewhat analogous to the formation of teratomas. Immun ohistochemical and ultrastructural studies support this theory. 8 Wick and Swanson favor the term sarcomatoid carcinoma for these compl ex neoplasms, but carcinosarcoma and spindle cell carcinoma continue to appea r in the literature and remain commonly accepted terms."
Hyams reported 39 cases of laryngeal sarcomatoid carcinoma.' The suprag lottis was the site of involvement in only two ofthese patients. Most of the 39 patient s were men (mean age: 68 years) who had a history of smoking. The spindle cell component predominated. The squamous cell co mponent was often at the base or stalk of polypoid tumors. Cervical metastases featured both carcinomatous and sarcomatous comp onents. These lesions were presum ed to be mucosal in origin. Eight of 20 patients available for followup had died of their disease between 4 month s and 2 years after diagnosis. Olse n et al reported 34 patie nts with laryngeal carc inosarcoma.' Th e clinica l feat ures of these patient s were remarkably simi lar to those reported by Hyams; smoki ng men in the seventh decade of life predominated. Survival rates were similar to those of patients who had pure squa mous ce ll carci noma of the larynx or hypoph arynx. Olsen et al recommended that interven tion be based on the tum or' s stage, location, and size, j ust as if these patients had co nventional squamous ce ll carcinoma. Thi s clinical behavior and therapeut ic approach support the co nce pt that these tumors are funda mentally carcinomas that simply contain areas of divergent differentiation .
Leve nto n and Eva ns analyze d the clinical outcomes of 20 patient s with head and neck sarcomatoi d carci noma, inclu din g three laryngeal tumors.' Nine of 10 patient s whose tumors had invaded muscle or bone died of disease. Co nversely, all 10 patients who had only superficially invasive tumors survive d.
Carci nosarcoma of salivary gland origin (so-ca lled true malignant mixed tumor) is rare. To our knowledge, ours is the first reported case of a laryngeal minor salivary glan d carc inosarcoma. T wenty-six salivary gland carcinosarcomas have been identified in the literatur e. 5 -7 • 9 -13 Th ree of these cases arose in the minor salivary glands of the palate, and the remainder occ urred in the parot id and submandibular glands. None has been described in the minor salivary glands of the supraglottis. Analysis of these 27 cases (including ours) reveals a wide age range (23 to 88 yea rs) and a slight predominance of wo men over men . Clinica l followup infor mation was ava ilable for 19 of the 27 patients. Fifteen died of disease, two were alive with disease, and two were alive without disease. Th e two patients wit hout disease were long-term survivors (>4 yr post-treatment), and in both of them, the tumor had originated in the parotid gland. 
